124 related articles for article (PubMed ID: 22048966)
21. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
22. Laron Syndrome: A Tale of Two Siblings.
Das N; Tarenia SS; Saha S; Gaikwad PM; Hathi DK; Goswami S; Baidya A; Sengupta N
J ASEAN Fed Endocr Soc; 2023; 38(2):124-127. PubMed ID: 38045665
[TBL] [Abstract][Full Text] [Related]
23. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
24. Characterization and prevalence of severe primary IGF1 deficiency in a large cohort of French children with short stature.
Teissier R; Flechtner I; Colmenares A; Lambot-Juhan K; Baujat G; Pauwels C; Samara-Boustani D; Beltrand J; Simon A; Thalassinos C; Crosnier H; Latrech H; Pinto G; Le Merrer M; Cormier-Daire V; Souberbielle JC; Polak M
Eur J Endocrinol; 2014 Jun; 170(6):847-54. PubMed ID: 24662318
[TBL] [Abstract][Full Text] [Related]
25. High growth hormone levels in clinically short stature children.
Awan TM; Sattar A; Khattak IG
J Ayub Med Coll Abbottabad; 2006; 18(2):29-33. PubMed ID: 16977810
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.
Carel JC; Chaussain JL; Chatelain P; Savage MO
Diabetes Metab; 1996 Jul; 22(4):251-6. PubMed ID: 8767171
[TBL] [Abstract][Full Text] [Related]
27. GH, IGF-I, and growth.
Isaksson O
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1321-6. PubMed ID: 15506078
[TBL] [Abstract][Full Text] [Related]
28. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
Smyczynska J; Hilczer M; Stawerska R; Lewinski A
Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone (GH) insensitivity due to primary GH receptor deficiency.
Rosenfeld RG; Rosenbloom AL; Guevara-Aguirre J
Endocr Rev; 1994 Jun; 15(3):369-90. PubMed ID: 8076588
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone insensitivity associated with elevated circulating growth hormone-binding protein in children with Alagille syndrome and short stature.
Bucuvalas JC; Horn JA; Carlsson L; Balistreri WF; Chernausek SD
J Clin Endocrinol Metab; 1993 Jun; 76(6):1477-82. PubMed ID: 8501153
[TBL] [Abstract][Full Text] [Related]
33. Partial growth hormone insensitivity.
Johnston LB; Savage MO
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():251-7. PubMed ID: 10698589
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of insulin-like growth factor-I in short stature.
Park MS; Kim DH
Yonsei Med J; 1989 Dec; 30(4):367-75. PubMed ID: 2626840
[TBL] [Abstract][Full Text] [Related]
35. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.
Backeljauw PF; Underwood LE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3312-7. PubMed ID: 8784089
[TBL] [Abstract][Full Text] [Related]
36. Functional and total IGFBP3 for the assessment of disorders of the GH/IGF1 axis in children with chronic kidney disease, GH deficiency, or short stature after SGA status at birth.
Büscher AK; Büscher R; Pridzun L; Langkamp M; Wachendorfer N; Hoyer PF; Ranke MB; Hauffa BP
Eur J Endocrinol; 2012 May; 166(5):923-31. PubMed ID: 22318747
[TBL] [Abstract][Full Text] [Related]
37. [Laron syndrome: Presentation, treatment and prognosis].
Latrech H; Polak M
Presse Med; 2016 Jan; 45(1):40-5. PubMed ID: 26564390
[TBL] [Abstract][Full Text] [Related]
38. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
Padidela R; Camacho-Hübner C; Attie KM; Savage MO
Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312
[TBL] [Abstract][Full Text] [Related]
39. Overnight growth hormone concentrations are usually normal in pubertal children with idiopathic short stature--a Clinical Research Center study.
Rose SR; Municchi G; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1996 Mar; 81(3):1063-8. PubMed ID: 8772577
[TBL] [Abstract][Full Text] [Related]
40. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
